Acute Myopericarditis After the Third Vaccination of BNT162b2 in a Middle-Aged Man
Acute Myopericarditis After the Third Vaccination of BNT162b2 in a Middle-Aged Man
About this item
Full title
Author / Creator
Publisher
Palo Alto: Cureus Inc
Journal title
Language
English
Formats
Publication information
Publisher
Palo Alto: Cureus Inc
Subjects
More information
Scope and Contents
Contents
Messenger ribonucleic acid (mRNA) vaccines against coronavirus disease 2019 (COVID-19) are highly effective in preventing and decreasing disease severity, but the duration of the effect is attenuated over time and repeated vaccination is required. A 41-year-old Japanese male presented to our hospital with chest pain three days after receiving the t...
Alternative Titles
Full title
Acute Myopericarditis After the Third Vaccination of BNT162b2 in a Middle-Aged Man
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9536864
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9536864
Other Identifiers
ISSN
2168-8184
E-ISSN
2168-8184
DOI
10.7759/cureus.28857
